Impilo Fund II is a Stockholm-based buy-out fund managed by Impilo. €700m reported at final close (source published June 2025).
Acquires majority stakes in Nordic healthcare businesses across pharmaceuticals, medical technology, specialist pharmaceutical services and related healthcare services.
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.